186 related articles for article (PubMed ID: 30130432)
1. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.
Keul P; Polzin A; Kaiser K; Gräler M; Dannenberg L; Daum G; Heusch G; Levkau B
FASEB J; 2019 Jan; 33(1):1482-1495. PubMed ID: 30130432
[TBL] [Abstract][Full Text] [Related]
2. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
4. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis.
Sattler K; Lehmann I; Gräler M; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
Cell Physiol Biochem; 2014; 34(1):172-84. PubMed ID: 24977490
[TBL] [Abstract][Full Text] [Related]
5. Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells.
Kimura T; Mogi C; Tomura H; Kuwabara A; Im DS; Sato K; Kurose H; Murakami M; Okajima F
J Immunol; 2008 Nov; 181(10):7332-40. PubMed ID: 18981156
[TBL] [Abstract][Full Text] [Related]
6. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.
Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-Phosphate and Atherosclerosis.
Kurano M; Yatomi Y
J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension.
Yogi A; Callera GE; Aranha AB; Antunes TT; Graham D; McBride M; Dominiczak A; Touyz RM
Hypertension; 2011 Apr; 57(4):809-18. PubMed ID: 21383307
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells.
Damirin A; Tomura H; Komachi M; Tobo M; Sato K; Mogi C; Nochi H; Tamoto K; Okajima F
Mol Pharmacol; 2005 Apr; 67(4):1177-85. PubMed ID: 15625281
[TBL] [Abstract][Full Text] [Related]
11. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
13. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells.
Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM
J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169
[TBL] [Abstract][Full Text] [Related]
15. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
[TBL] [Abstract][Full Text] [Related]
16. Cellular function and signaling pathways of vascular smooth muscle cells modulated by sphingosine 1-phosphate.
Machida T; Matamura R; Iizuka K; Hirafuji M
J Pharmacol Sci; 2016 Dec; 132(4):211-217. PubMed ID: 27581589
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
19. Neonatal HDL Counteracts Placental Vascular Inflammation via S1P-S1PR1 Axis.
Del Gaudio I; Hendrix S; Christoffersen C; Wadsack C
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991780
[TBL] [Abstract][Full Text] [Related]
20. TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis.
Ito S; Iwaki S; Kondo R; Satoh M; Iwabuchi K; Ohkawa R; Mishima Y; Yatomi Y; Furumoto T; Tsutsui H; Fujii S
Coron Artery Dis; 2014 Jun; 25(4):311-20. PubMed ID: 24448174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
